The national Asthma Biologics programme has now completed and has made substantial contributions to the transformation of asthma care in England while significantly increasing the access to and adoption of asthma biologics. Learning from the FeNO and Asthma Biologics AHSN programmes is being fed into the development of NICE/SIGN/British Thoracic Society asthma guidance, expected in 2024, offering real world insights to implementation considerations.
There are opportunities to continue this work and improve asthma care by enhancing rollout of the innovations and ensure more patients can benefit. The toolkits, training modules and other resources created during the programme will remain accessible to NHS clinicians following the end of the AHSN programme.
The Health Innovation Network is transitioning to support healthcare inequalities as a national priority as part of NHS England’s Innovation for Healthcare Inequalities Programme (InHIP). Building on the transforming asthma pathways work, a number of AHSNs will support the respiratory aspect of the NHS England Core20PLUS5 approach, continuing to utilise the implementation and educational resources developed for the Asthma Biologics national programme.